3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Melanoma
13
Carcinoma, Hepatocellular
13
Neoplasm Metastasis
12
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Neoplasms
9
Esophageal Neoplasms
9
Colorectal Neoplasms
6
Esophageal Squamous Cell Carcinoma
5
Breast Neoplasms
5
Recurrence
4
Rectal Neoplasms
4
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Liver Neoplasms
3
Head and Neck Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Radiation Pneumonitis
2
Prostatic Neoplasms
2
Pathologic Complete Response
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neuroblastoma
2
Interventions
pembrolizumab
3
enzalutamide
2
blinatumomab
2
abiraterone
2
Stents
2
Neoadjuvant Therapy
2
Immune Checkpoint Inhibitors
2
Cytochrome P-450 Enzyme System
2
soybean oil, phospholipid emulsion
1
durvalumab
1
dostarlimab
1
cemiplimab
1
camrelizumab
1
atezolizumab
1
Surgical Procedures, Operative
1
Surgical Instruments
1
Radiotherapy, Conformal
1
Radiotherapy
1
Passive Cutaneous Anaphylaxis
1
Palliative Care
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Morphine
1
Lidocaine
1
Levobupivacaine
1
Immunotherapy
1
Hydroxyurea
1
Etoposide
1
Etanercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Bites and Stings
×
Immunotherapy
×
Clear all
NCT05202314
2023-02-21
NACSOC-02
Beijing Chao Yang Hospital
Phase NA
Recruiting
20 enrolled